Pfizer Is Weighing Sale of $2 Billion-Women's Health Portfolio
Pfizer Inc.’s Zoloft tablets are arranged for a photograph in New Delhi. (Photographer: Sondeep Shankar/Bloomberg News.)

Pfizer Is Weighing Sale of $2 Billion-Women's Health Portfolio

(Bloomberg) -- Pfizer Inc. is reviewing options including a sale of its women’s health portfolio as the U.S. pharmaceutical giant seeks to focus on developing treatments with higher growth potentia...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.